FR2253508B1 - - Google Patents

Info

Publication number
FR2253508B1
FR2253508B1 FR7413730A FR7413730A FR2253508B1 FR 2253508 B1 FR2253508 B1 FR 2253508B1 FR 7413730 A FR7413730 A FR 7413730A FR 7413730 A FR7413730 A FR 7413730A FR 2253508 B1 FR2253508 B1 FR 2253508B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7413730A
Other versions
FR2253508A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EDELFETTWERKE WERNER SCHLUTER
Original Assignee
EDELFETTWERKE WERNER SCHLUTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EDELFETTWERKE WERNER SCHLUTER filed Critical EDELFETTWERKE WERNER SCHLUTER
Publication of FR2253508A1 publication Critical patent/FR2253508A1/fr
Application granted granted Critical
Publication of FR2253508B1 publication Critical patent/FR2253508B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7413730A 1973-12-06 1974-04-19 Expired FR2253508B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732360796 DE2360796B2 (de) 1973-12-06 1973-12-06 Arzneimittel mit verzoegerter abgabe des wirkstoffs im darm

Publications (2)

Publication Number Publication Date
FR2253508A1 FR2253508A1 (fr) 1975-07-04
FR2253508B1 true FR2253508B1 (fr) 1977-11-10

Family

ID=5900064

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7413730A Expired FR2253508B1 (fr) 1973-12-06 1974-04-19

Country Status (11)

Country Link
US (1) US4013784A (fr)
JP (1) JPS5089521A (fr)
AR (1) AR204629A1 (fr)
BE (1) BE811175A (fr)
DE (1) DE2360796B2 (fr)
DK (1) DK137310C (fr)
ES (1) ES423856A1 (fr)
FR (1) FR2253508B1 (fr)
GB (1) GB1427677A (fr)
NL (1) NL7407233A (fr)
SE (1) SE7407537L (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US5112619A (en) * 1985-11-12 1992-05-12 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulation
HU202753B (en) * 1986-06-21 1991-04-29 Sandoz Ag Process for producing retard pharmaceutical compositions containing cetotiphene
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE68906461T2 (de) * 1988-06-07 1993-10-21 Abbott Lab Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung.
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
EP0366058A3 (fr) * 1988-10-27 1991-03-20 Abbott Laboratories Dispositif de délivrance à libération contrôlée, procédé de préparation du dispositif et méthode d'utilisation du dispositif
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
SE9200858L (sv) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Metod för framställning av pellets med fördröjd frisättning
IL109460A (en) 1993-05-10 1998-03-10 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US6187337B1 (en) 1994-01-27 2001-02-13 The Board Of Regents Of The University Of Oklahoma Rapidly dissolving dosage form
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US6066337A (en) * 1994-01-27 2000-05-23 The Board Of Regents Of The University Of Oklahoma And Janssen Pharmaceutica, Inc. Method for producing a rapidly dissolving dosage form
US6207199B1 (en) 1994-01-27 2001-03-27 The Board Of Regents Of The University Of Oklahoma Process for making a particulate support matrix for making a rapidly dissolving dosage form
US6177104B1 (en) 1994-01-27 2001-01-23 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving dosage form
US5635210A (en) * 1994-02-03 1997-06-03 The Board Of Regents Of The University Of Oklahoma Method of making a rapidly dissolving tablet
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10300325A1 (de) * 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
US6992772B2 (en) * 2003-06-19 2006-01-31 Optix Lp Method and apparatus for optical sampling to reduce interfering variances
US20040265378A1 (en) * 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
US20070082027A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Jr Compositions and methods for reducing food intake and controlling weight
US20070082029A1 (en) * 2005-10-07 2007-04-12 Aimutis William R Fiber satiety compositions
DE102013106998A1 (de) * 2013-07-03 2015-01-08 Thyssenkrupp Industrial Solutions Ag Verfahren sowie eine Vorrichtung zur Herstellung einer Tablette
US10647045B1 (en) * 2016-11-03 2020-05-12 Specialty Earth Sciences, Llc Shaped or sized encapsulated reactant and method of making

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
US3629393A (en) * 1969-09-11 1971-12-21 Nikken Chemicals Co Ltd Release-sustaining-tablet

Also Published As

Publication number Publication date
BE811175A (fr) 1974-06-17
AR204629A1 (es) 1976-02-20
DK137310C (da) 1978-07-24
JPS5089521A (fr) 1975-07-18
DE2360796A1 (de) 1975-06-12
ES423856A1 (es) 1976-05-01
DK137310B (da) 1978-02-20
DE2360796B2 (de) 1977-06-02
NL7407233A (nl) 1975-06-10
FR2253508A1 (fr) 1975-07-04
SE7407537L (fr) 1975-06-09
US4013784A (en) 1977-03-22
GB1427677A (en) 1976-03-10
DK303974A (fr) 1975-07-28

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
FR2253508B1 (fr)
AR201229Q (fr)
AR199451A1 (fr)
AU477823B2 (fr)
FR2213532A1 (fr)
AR197627A1 (fr)
AR193950A1 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AR201432A1 (fr)
AR195311A1 (fr)
AR200885A1 (fr)
AR196382A1 (fr)
AR200256A1 (fr)
AR195948A1 (fr)
AR196212Q (fr)
AR196123Q (fr)
BG19709A1 (fr)
CH564723A5 (fr)
CH559268A5 (fr)
AU479420A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse